About us

About us

About us

Embleema is a technology platform for registries and real-world studies that serves patients and unifies genomic, clinical, and patient-reported data, generating regulatory-grade evidence for research organizations and life science sponsors.

Embleema is a technology platform for registries and real-world studies that serves patients and unifies genomic, clinical, and patient-reported data, generating regulatory-grade evidence for research organizations and life science sponsors.

Embleema was founded to address a core challenge in medical research: transforming fragmented, complex health data into evidence for advancing new cures for precision medicine. The company is built on a platform originally developed in collaboration with the FDA, which enables research teams to collect, process, and structure data from patients, study sites, electronic medical records, wearables, and biospecimens into regulatory-grade datasets.

Embleema was founded to address a core challenge in medical research: transforming fragmented, complex health data into evidence for advancing new cures for precision medicine. The company is built on a platform originally developed in collaboration with the FDA, which enables research teams to collect, process, and structure data from patients, study sites, electronic medical records, wearables, and biospecimens into regulatory-grade datasets.

Embleema was founded to address a core challenge in medical research: transforming fragmented, complex health data into evidence for advancing new cures for precision medicine. The company is built on a platform originally developed in collaboration with the FDA, which enables research teams to collect, process, and structure data from patients, study sites, electronic medical records, wearables, and biospecimens into regulatory-grade datasets.

Embleema supports site-based, hybrid, and decentralized research through a flexible platform purpose-built for long-term non-interventional studies, while at the same time providing participants with digital services useful for their everyday care. This allows pharmaceutical companies, research foundations, and academic institutions to design and manage studies that are more adaptive, inclusive, and efficient.

Embleema supports site-based, hybrid, and decentralized research through a flexible platform purpose-built for long-term non-interventional studies, while at the same time providing participants with digital services useful for their everyday care. This allows pharmaceutical companies, research foundations, and academic institutions to design and manage studies that are more adaptive, inclusive, and efficient.

Embleema supports site-based, hybrid, and decentralized research through a flexible platform purpose-built for long-term non-interventional studies, while at the same time providing participants with digital services useful for their everyday care. This allows pharmaceutical companies, research foundations, and academic institutions to design and manage studies that are more adaptive, inclusive, and efficient.

We help advance precision medicine by breaking down barriers and capturing data that is often inaccessible to traditional research—everyday care, routine clinical visits, and real-life experiences of those managing chronic or complex conditions.

The name Embleema comes from the Greek emblema, meaning a detailed mosaic or inlay—reflecting our mission to bring together the many pieces of the patient experience into a complete, meaningful picture that advances discovery of new cures and better care.

We help advance precision medicine by breaking down barriers and capturing data that is often inaccessible to traditional research—everyday care, routine clinical visits, and real-life experiences of those managing chronic or complex conditions.

The name Embleema comes from the Greek emblema, meaning a detailed mosaic or inlay—reflecting our mission to bring together the many pieces of the patient experience into a complete, meaningful picture that advances discovery of new cures and better care.

We help advance precision medicine by breaking down barriers and capturing data that is often inaccessible to traditional research—everyday care, routine clinical visits, and real-life experiences of those managing chronic or complex conditions.

The name Embleema comes from the Greek emblema, meaning a detailed mosaic or inlay—reflecting our mission to bring together the many pieces of the patient experience into a complete, meaningful picture that advances discovery of new cures and better care.

Our mission

We partner with patients to generate evidence, recognizing their central role in driving collaboration across the research ecosystem and accelerating the advancement of precision medicine.

Our mission

We partner with patients to generate evidence, recognizing their central role in driving collaboration across the research ecosystem and accelerating the advancement of precision medicine.

Our mission

We partner with patients to generate evidence, recognizing their central role in driving collaboration across the research ecosystem and accelerating the advancement of precision medicine.

Our values

Trust

We build lasting trust with sponsors, investigators, and patients by ensuring data privacy, maintaining transparency, and consistently delivering reliable, high-quality results.

Patient-centricity

We design every experience to empower patients as active partners in research, giving them control of their data, simplifying participation, and creating meaningful value in both care and research.

Integrity

We uphold the highest ethical and regulatory standards by protecting patient data, meeting global compliance requirements, and honoring our responsibility to both participants and research.

Collaboration

We bring sponsors, site staff, and patients together in a unified research ecosystem through streamlined operations and a shared purpose, reducing complexity and accelerating insights.

Meet the team

A headshot of Robert Chu

Robert Chu

CEO & Co-Founder

Robert, former SVP of Global Technology at IQVIA, has built and managed data networks in over 20 countries across the U.S., Asia, and Europe. He uses expertise to go the extra mile for clients.

A headshot of Nicolas Schmidt

Nicolas Schmidt

Chief Product Officer & Co-Founder

Formerly at Withings & Head of Healthcare Products at Nokia, Nicolas focuses on building innovations that help patients regain control of their health data and share them transparently.

A headshot of Vahan Simonyan Ph.D.

Vahan Simonyan Ph.D.

Chief Scientist

Dr. Vahan Simonyan, former FDA lead scientist, leverages expertise in biotechnology, bioinformatics, and digital healthcare to drive innovation in research and regulatory infrastructure.

A headshot of Elaine Thompson, Ph.D.

Elaine Thompson, Ph.D.

Vice President, Bioinformatics

Elaine formerly directed a pathology AI/ML team as a Navy contractor. She has a background in FDA, bioinformatics, and clinical trials for new diagnostics and therapeutics development.

A headshot of Tim Evain

Tim Evain

VP of Engineering

Former Co-Founder and CTO of Imageens, building clinically validated predictive biomarkers and apps in Cardiovascular diseases. PhD in medical imaging processing and 10+ years of experience in medical software space.

A headshot of Aaron Smith

Aaron Smith

Head of Clinical Operations

Aaron leads our study clinical coordination activities, working with our sites and participants to ensure high data quality and density. Formerly a central research coordinator at NYU Langone, Aaron is also a practicing Registered Nurse caring for patients.

A headshot of Alana Matos

Alana Matos

Lead Product Designer

Alana has over 10 years of UX and product design experience with The Economist, Meta, Chick-fil-A, and health-tech startups. She specializes in crafting intuitive user experiences that drive product-market fit and empower patients.

A headshot of Tamar Kuyumjian

Tamar Kuyumjian

Founding Marketer

Tamar has 6+ years of experience in marketing, leading integrated campaign strategy and execution for B2B and B2B2C. She bridges marketing, sales, operations, product, executive, and agency teams to develop cohesive go-to-market strategies that scale growth and optimize spend.

A headshot of Naira Stepanyan

Naira Stepanyan

Client Success Manager

Naira was a former technical writer. She ensures that clients are successfully using the platform through user support, training, data quality, migration procedures and reference data curation.

Partner with us

See how Embleema supports compliant, scalable research from protocol setup to final submission.

Partner with us

See how Embleema supports compliant, scalable research from protocol setup to final submission.

Partner with us

See how Embleema supports compliant, scalable research from protocol setup to final submission.